Does TREPROSTINIL Cause Supraventricular tachycardia? 113 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Supraventricular tachycardia have been filed in association with TREPROSTINIL (TYVASO). This represents 0.1% of all adverse event reports for TREPROSTINIL.
113
Reports of Supraventricular tachycardia with TREPROSTINIL
0.1%
of all TREPROSTINIL reports
18
Deaths
91
Hospitalizations
How Dangerous Is Supraventricular tachycardia From TREPROSTINIL?
Of the 113 reports, 18 (15.9%) resulted in death, 91 (80.5%) required hospitalization, and 10 (8.8%) were considered life-threatening.
Is Supraventricular tachycardia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Supraventricular tachycardia?
ADALIMUMAB (141)
METOPROLOL (132)
ROSIGLITAZONE (114)
RITUXIMAB (99)
ALBUTEROL (98)
IBRUTINIB (96)
DEXAMETHASONE (95)
ASPIRIN (92)
LEVOTHYROXINE (91)
PACLITAXEL (86)
Which TREPROSTINIL Alternatives Have Lower Supraventricular tachycardia Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE